Vetter has launched a new syringe closure system for filling highly sensitive compounds such as biologics.
Consisting of a needle hub and a needle shield, the new syringe closure system, called Vetter-Ject, is partly produced by means of a two-component injection moulding process of polypropylene and thermoplastic elastomer.
Vetter Packaging Development director Tilman Roedle said: "Our patented syringe closure system offers pharmaceutical and biotech companies more options for filling highly sensitive parenteral drugs.
"Patients and qualified medical personnel now have the advantage of the system’s easy handling and high standards for product safety and integrity."
The novel closure system is primarily suitable for silicon-sensitive drug products due to the baked-in siliconisation process for the glass barrel, which needs less silicon oil than the amount used in conventional syringe systems.
In addition, customers can modify the silicon content of the syringe according to their requirements.
Vetter-Ject is ready-to-use with an integrated needle that is simple to handle and user-friendly, and has a tamper-evident closure that makes any attempt at opening the closure system immediately and permanently visible to the naked eye.
The product attribute is activated when the needle shield is removed and plastic bridges are broken, preventing any potential misuse or reuse.
The system can be used with a broad spectrum of primary packaging options such as different stoppers and glass barrels, which can be customised according to the needs of the drug product.
Vetter also offers the assembly and final packaging of Vetter-Ject syringe systems, from trays and plunger rod assembly, to auto-injector assembly and final packaging, as part of its packaging service.
Image: Vetter-Ject is a new syringe closure system designed for filling highly sensitive compounds. Photo: courtesy of Business Wire.
